Year 2025,
Volume: 42 Issue: 3, 349 - 355, 30.09.2025
Nilüfer Gürsoy
,
Elif Çelebi
,
İrfan Sarıca
References
-
Lee SJ, Flowers ME. Recognizing and managing chronic graft-versus-host disease. ASH Education Program Book. 2008;2008(1):134-41.
-
Tollemar V, Garming Legert K, Sugars RV. Perspectives on oral chronic graft-versus-host disease from
immunobiology to morbid diagnoses. Frontiers in Immunology. 2023;14:1151493.
-
Li D, Shan Y, Sun W, Wang X, Duo L. Multiple Oral Manifestations in a Patient With Chronic Graft Versus Host
Disease: A Case Report. Cureus. 2024;16(9).
-
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health consensus
development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and
Staging Working Group report. Biology of Blood and Marrow Transplantation. 2015;21(3):389-401. e1.
-
Lazaryan A, Arora M. Evolving concepts in prognostic scoring of chronic GvHD. Bone marrow transplantation.
2017;52(10):1361-6.
-
Pavletic SZ, Martin PJ, Schultz KR, Lee SJ. The future of chronic graft-versus-host disease: introduction to the 2020
National Institutes of Health Consensus Development Project reports. Transplantation and Cellular Therapy,
Official Publication of the American Society for Transplantation and Cellular Therapy. 2021;27(6):448-51.
-
Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, et al. Ancillary therapy and
supportive care of chronic graft-versus-host disease: national institutes of health consensus development
project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care
Working Group Report. Biology of Blood and Marrow Transplantation. 2006;12(4):375-96.
-
Kariminia A, Holtan SG, Ivison S, Rozmus J, Hebert M-J, Martin PJ, et al. Heterogeneity of chronic graft-versus-host
disease biomarkers: association with CXCL10 and CXCR3+ NK cells. Blood, The Journal of the American Society of
Hematology. 2016;127(24):3082-91.
-
Qiu X, Yu T, Xu Y. A Rare Case of Tongue Neoplasia Treated Successfully in a Patient With B-Cell Acute
Lymphoblastic Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Craniofacial
Surgery. 2021;32(5):e452-e4.
-
Hashimoto K, Nagao T, Koie S, Miyabe S, Saito T. Secondary squamous cell carcinoma of the tongue complicated
with bronchiolitis obliterans as a manifestation of graft‐versus‐host disease following peripheral blood stem cell
transplantation. Case Reports in Hematology. 2019;2019(1):6015803.
-
Kaffenberger BH, Huff SB, Vasu S. Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid
resolution with rituximab. International Journal of Dermatology. 2019;58(2).
-
Kaya H, Okumura H, Ishizawa S. Improvement of chronic GVHD after oral treatment with Clostridium butyricum
(Miya BM). Anaerobe. 2022;76:102612.
-
Spałek A, Grygoruk-Wiśniowska I, Gruenpeter K, Panz-Klapuch M, Helbig G. Spectacular and Prompt Response to
Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic
Hematopoietic Stem Cell Transplantation: A Case Report. Medicina. 2022;58(12):1722.
-
Wu T, Liu Z, Yong X, Mei G, Jiang Q, Fang M, et al. P16-positive secondary tongue squamous cell carcinoma
following allogeneic hematopoietic stem cell transplantation: A case report and literature review. Oral Oncology.
2021;121:105399.
-
Woelfinger P, Hauptrock B, Kriege O, Wagner W, Heider J, Schwarting A, et al., editors. Alloimmune Myositis as
Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or
a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion. Transplantation
Proceedings; 2021: Elsevier.
-
Epstein JB, Raber-Durlacher JE, Epstein GL, Hazenberg MD, Tzachanis D, Spielberger RT. Chronic oral graft-versus-
host disease: induction and maintenance therapy with photobiomodulation therapy. Supportive Care in Cancer.
2021;29:1387-94.
-
Liu Y, Yuan W, Li M, Cheng L, Yang J, Yin B, et al. In situ buccal carcinoma in a teenager after hematopoietic stem
cell transplantation: A case report. Medicine. 2020;99(43):e22781.
-
Campos L, Rezende SB, Simoes A, Palma LF, Tateno RY, da Silva RL, et al. Photobiomodulation and photodynamic
therapy for the management of oral graft-versus-host disease: A case report. Photodiagnosis and Photodynamic
Therapy. 2020;30:101776.
-
Teoh CS, Goh AS. Relapsed chronic lymphocytic leukaemia with concomitant extensive chronic Graft versus host
disease after allogeneic haematopoietic stem cell transplantation successfully treated with oral venetoclax.
Case reports in transplantation. 2021;2021(1):8831125.
-
Leidens N, Ballardin BS, Leal GA, de Araújo AMM, Sessenta‐Junior CF, Torres‐Pereira CC, et al. Graft‐versus‐host
disease and herpes simplex virus oral injuries in onco‐hematological patient: Case report. Special Care in
Dentistry. 2022;42(1).
-
Rezende SB, Campos L, Palma LF, Tateno RY, Simões A, Macedo MC, et al. Antimicrobial photodynamic therapy for
recurrent herpes labialis in chronic graft‐versus‐host disease: A case report. Photodermatology,
Photoimmunology & Photomedicine. 2021;37(4).
-
Liu Z, Peng Y, Yong X, Mei G, Yang Y, Yi C, et al. A case report of secondary oral squamous cell carcinoma after
allogeneic hematopoietic stem cell transplantation. Oral oncology. 2020;109:104629.
Oral manifestations of chronic graft-versus-host disease in leukemia patients: A case Series and brief literature review
Year 2025,
Volume: 42 Issue: 3, 349 - 355, 30.09.2025
Nilüfer Gürsoy
,
Elif Çelebi
,
İrfan Sarıca
Abstract
Chronic graft-versus-host disease (cGVHD) is a common complication following allogeneic hematopoietic cell transplantation, frequently involves the oral cavity and may present as the initial manifestation. This study included three cases of oral cGVHD in patients (one woman and two men aged 53, 57, and 43) who underwent hematopoietic cell transplantation for leukemia, along with a brief literature review. The patients predominantly exhibited oral manifestations, including lichen-like lesions, erythema, and ulcerations. Additionally, one case presented with hyperpigmentation, while another developed chronic hyperplastic candidiasis. This study aims to present the oral findings of three cases of oral cGVHD and to analyze relevant cases reported in previous research for comparison.
Ethical Statement
Informed consent: Informed consent was obtained to confirm patients’ permission.
References
-
Lee SJ, Flowers ME. Recognizing and managing chronic graft-versus-host disease. ASH Education Program Book. 2008;2008(1):134-41.
-
Tollemar V, Garming Legert K, Sugars RV. Perspectives on oral chronic graft-versus-host disease from
immunobiology to morbid diagnoses. Frontiers in Immunology. 2023;14:1151493.
-
Li D, Shan Y, Sun W, Wang X, Duo L. Multiple Oral Manifestations in a Patient With Chronic Graft Versus Host
Disease: A Case Report. Cureus. 2024;16(9).
-
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health consensus
development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and
Staging Working Group report. Biology of Blood and Marrow Transplantation. 2015;21(3):389-401. e1.
-
Lazaryan A, Arora M. Evolving concepts in prognostic scoring of chronic GvHD. Bone marrow transplantation.
2017;52(10):1361-6.
-
Pavletic SZ, Martin PJ, Schultz KR, Lee SJ. The future of chronic graft-versus-host disease: introduction to the 2020
National Institutes of Health Consensus Development Project reports. Transplantation and Cellular Therapy,
Official Publication of the American Society for Transplantation and Cellular Therapy. 2021;27(6):448-51.
-
Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, et al. Ancillary therapy and
supportive care of chronic graft-versus-host disease: national institutes of health consensus development
project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care
Working Group Report. Biology of Blood and Marrow Transplantation. 2006;12(4):375-96.
-
Kariminia A, Holtan SG, Ivison S, Rozmus J, Hebert M-J, Martin PJ, et al. Heterogeneity of chronic graft-versus-host
disease biomarkers: association with CXCL10 and CXCR3+ NK cells. Blood, The Journal of the American Society of
Hematology. 2016;127(24):3082-91.
-
Qiu X, Yu T, Xu Y. A Rare Case of Tongue Neoplasia Treated Successfully in a Patient With B-Cell Acute
Lymphoblastic Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Craniofacial
Surgery. 2021;32(5):e452-e4.
-
Hashimoto K, Nagao T, Koie S, Miyabe S, Saito T. Secondary squamous cell carcinoma of the tongue complicated
with bronchiolitis obliterans as a manifestation of graft‐versus‐host disease following peripheral blood stem cell
transplantation. Case Reports in Hematology. 2019;2019(1):6015803.
-
Kaffenberger BH, Huff SB, Vasu S. Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid
resolution with rituximab. International Journal of Dermatology. 2019;58(2).
-
Kaya H, Okumura H, Ishizawa S. Improvement of chronic GVHD after oral treatment with Clostridium butyricum
(Miya BM). Anaerobe. 2022;76:102612.
-
Spałek A, Grygoruk-Wiśniowska I, Gruenpeter K, Panz-Klapuch M, Helbig G. Spectacular and Prompt Response to
Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic
Hematopoietic Stem Cell Transplantation: A Case Report. Medicina. 2022;58(12):1722.
-
Wu T, Liu Z, Yong X, Mei G, Jiang Q, Fang M, et al. P16-positive secondary tongue squamous cell carcinoma
following allogeneic hematopoietic stem cell transplantation: A case report and literature review. Oral Oncology.
2021;121:105399.
-
Woelfinger P, Hauptrock B, Kriege O, Wagner W, Heider J, Schwarting A, et al., editors. Alloimmune Myositis as
Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or
a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion. Transplantation
Proceedings; 2021: Elsevier.
-
Epstein JB, Raber-Durlacher JE, Epstein GL, Hazenberg MD, Tzachanis D, Spielberger RT. Chronic oral graft-versus-
host disease: induction and maintenance therapy with photobiomodulation therapy. Supportive Care in Cancer.
2021;29:1387-94.
-
Liu Y, Yuan W, Li M, Cheng L, Yang J, Yin B, et al. In situ buccal carcinoma in a teenager after hematopoietic stem
cell transplantation: A case report. Medicine. 2020;99(43):e22781.
-
Campos L, Rezende SB, Simoes A, Palma LF, Tateno RY, da Silva RL, et al. Photobiomodulation and photodynamic
therapy for the management of oral graft-versus-host disease: A case report. Photodiagnosis and Photodynamic
Therapy. 2020;30:101776.
-
Teoh CS, Goh AS. Relapsed chronic lymphocytic leukaemia with concomitant extensive chronic Graft versus host
disease after allogeneic haematopoietic stem cell transplantation successfully treated with oral venetoclax.
Case reports in transplantation. 2021;2021(1):8831125.
-
Leidens N, Ballardin BS, Leal GA, de Araújo AMM, Sessenta‐Junior CF, Torres‐Pereira CC, et al. Graft‐versus‐host
disease and herpes simplex virus oral injuries in onco‐hematological patient: Case report. Special Care in
Dentistry. 2022;42(1).
-
Rezende SB, Campos L, Palma LF, Tateno RY, Simões A, Macedo MC, et al. Antimicrobial photodynamic therapy for
recurrent herpes labialis in chronic graft‐versus‐host disease: A case report. Photodermatology,
Photoimmunology & Photomedicine. 2021;37(4).
-
Liu Z, Peng Y, Yong X, Mei G, Yang Y, Yi C, et al. A case report of secondary oral squamous cell carcinoma after
allogeneic hematopoietic stem cell transplantation. Oral oncology. 2020;109:104629.